{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,9]],"date-time":"2024-06-09T19:31:51Z","timestamp":1717961511089},"reference-count":73,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2013,10,17]],"date-time":"2013-10-17T00:00:00Z","timestamp":1381968000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0077879","type":"journal-article","created":{"date-parts":[[2013,10,17]],"date-time":"2013-10-17T21:13:15Z","timestamp":1382044395000},"page":"e77879","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":8,"title":["Use of a Recombinant Vaccinia Virus Expressing Interferon Gamma for Post-Exposure Protection against Vaccinia and Ectromelia Viruses"],"prefix":"10.1371","volume":"8","author":[{"given":"Susan A.","family":"Holechek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen L.","family":"Denzler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael C.","family":"Heck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jill","family":"Schriewer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. Mark","family":"Buller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatema A.","family":"Legrand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulo H.","family":"Verardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leslie A.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tilahun","family":"Yilma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bertram L.","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2013,10,17]]},"reference":[{"key":"ref1","article-title":"The Orthopoxviruses","author":"F Fenner","year":"1989"},{"key":"ref2","first-page":"2849","article-title":"Poxviridae: the viruses and their replication","year":"2001"},{"key":"ref3","article-title":"The Global Eradication of Smallpox: Final Report of the Global Commission for the Certification of Smallpox Eradication. Geneva. 1-122 p","year":"1980"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1086\/375823","article-title":"Separate worlds set to collide: smallpox, vaccinia virus vaccination, and human immunodeficiency virus and acquired immunodeficiency syndrome","volume":"37","author":"VK Amorosa","year":"2003","journal-title":"Clin Infect Dis"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0196-0644(03)00629-2","article-title":"Emergency medicine tools to manage smallpox (vaccinia) vaccination complications: clinical practice guideline and policies and procedures","volume":"42","author":"CD Thorne","year":"2003","journal-title":"Ann Emerg Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"743","DOI":"10.3201\/eid0807.020032","article-title":"Smallpox research activities: U.S. interagency collaboration, 2001","volume":"8","author":"JW LeDuc","year":"2002","journal-title":"Emerg Infect Dis"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1086\/498155","article-title":"Reemergence of monkeypox: prevalence, diagnostics, and countermeasures","volume":"41","author":"A Nalca","year":"2005","journal-title":"Clin Infect Dis"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/rmv.439","article-title":"Therapeutic potential of nucleoside\/nucleotide analogues against poxvirus infections","volume":"14","author":"E De Clercq","year":"2004","journal-title":"Rev Med Virol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/nature04295","article-title":"Antiviral treatment is more effective than smallpox vaccination upon lethal monkeypox virus infection","volume":"439","author":"KJ Stittelaar","year":"2006","journal-title":"Nature"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ijid.2005.12.001","article-title":"Vaccinia immune globulin: current policies, preparedness, and product safety and efficacy","volume":"10","author":"R Wittek","year":"2006","journal-title":"Int J Infect Dis"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1128\/AAC.01044-08","article-title":"In vitro efficacy of ST246 against smallpox and monkeypox","volume":"53","author":"SK Smith","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"13139","DOI":"10.1128\/JVI.79.20.13139-13149.2005","article-title":"An orally bioavailable antipoxvirus compound (ST-246) inhibits extracellular virus formation and protects mice from lethal orthopoxvirus Challenge","volume":"79","author":"G Yang","year":"2005","journal-title":"J Virol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1128\/AAC.00879-06","article-title":"Efficacy of delayed treatment with ST-246 given orally against systemic orthopoxvirus infections in mice","volume":"51","author":"DC Quenelle","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"4118","DOI":"10.1128\/AAC.00762-07","article-title":"Synergistic efficacy of the combination of ST-246 with CMX001 against orthopoxviruses","volume":"51","author":"DC Quenelle","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.antiviral.2008.03.005","article-title":"Evaluation of orally delivered ST-246 as postexposure prophylactic and antiviral therapeutic in an aerosolized rabbitpox rabbit model","volume":"79","author":"A Nalca","year":"2008","journal-title":"Antiviral Res"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.3390\/v2122740","article-title":"Development of CMX001 for the Treatment of Poxvirus Infections","volume":"2","author":"R Lanier","year":"2010","journal-title":"Viruses"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"768","DOI":"10.4269\/ajtmh.2007.76.768","article-title":"Efficacy of the antipoxvirus compound ST-246 for treatment of severe orthopoxvirus infection","volume":"76","author":"E Sbrana","year":"2007","journal-title":"Am J Trop Med Hyg"},{"key":"ref18","first-page":"478","article-title":"Household transmission of vaccinia virus from contact with a military smallpox vaccinee--Illinois and Indiana, 2007","volume":"56","year":"2007","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1086\/587668","article-title":"Severe eczema vaccinatum in a household contact of a smallpox vaccinee","volume":"46","author":"S Vora","year":"2008","journal-title":"Clin Infect Dis"},{"key":"ref20","first-page":"532","article-title":"Progressive vaccinia in a military smallpox vaccinee - United States, 2009","volume":"58","year":"2009","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref21","first-page":"1204","article-title":"Human vaccinia infection after contact with a raccoon rabies vaccine bait - Pennsylvania, 2009","volume":"58","year":"2009","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1086\/374054","article-title":"Can postexposure vaccination against smallpox succeed?","volume":"36","author":"PP Mortimer","year":"2003","journal-title":"Clin Infect Dis"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1086\/595565","article-title":"Postexposure immunization with modified vaccinia virus Ankara or conventional Lister vaccine provides solid protection in a murine model of human smallpox","volume":"199","author":"N Paran","year":"2009","journal-title":"J Infect Dis"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1099\/vir.0.82068-0","article-title":"Short-term, but not post-exposure, protection against lethal orthopoxvirus challenge after immunization with modified vaccinia virus Ankara","volume":"87","author":"C Staib","year":"2006","journal-title":"J Gen Virol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/329545a0","article-title":"Recovery of immunodeficient mice from a vaccinia virus\/IL-2 recombinant infection","volume":"329","author":"IA Ramshaw","year":"1987","journal-title":"Nature"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1126\/science.8009221","article-title":"Functional role of type I and type II interferons in antiviral defense","volume":"264","author":"U M\u00fcller","year":"1994","journal-title":"Science"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"7103","DOI":"10.1128\/JVI.70.10.7103-7107.1996","article-title":"Interleukin-4 mediates down regulation of antiviral cytokine expression and cytotoxic T-lymphocyte responses and exacerbates vaccinia virus infection in vivo","volume":"70","author":"DP Sharma","year":"1996","journal-title":"J Virol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/330259a0","article-title":"Prevention of vaccinia virus infection in immunodeficient mice by vector-directed IL-2 expression","volume":"330","author":"C Flexner","year":"1987","journal-title":"Nature"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1099\/vir.0.19120-0","article-title":"IL-12 and IL-18 act in synergy to clear vaccinia virus infection: involvement of innate and adaptive components of the immune system","volume":"84","author":"MM Gherardi","year":"2003","journal-title":"J Gen Virol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1006\/viro.1997.8881","article-title":"Complementation of vaccinia virus deleted of the E3L gene by mutants of E3L","volume":"239","author":"T Shors","year":"1997","journal-title":"Virology"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1128\/JVI.75.2.850-856.2001","article-title":"Both carboxy- and amino-terminal domains of the vaccinia virus interferon resistance gene, E3L, are required for pathogenesis in a mouse model","volume":"75","author":"TA Brandt","year":"2001","journal-title":"J Virol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1073\/pnas.0409846102","article-title":"Vaccinia viruses with a serpin gene deletion and expressing IFN-gamma induce potent immune responses without detectable replication in vivo","volume":"102","author":"FA Legrand","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1128\/JVI.71.3.1992-2003.1997","article-title":"Double-stranded RNA is a trigger for apoptosis in vaccinia virus-infected cells","volume":"71","author":"KV Kibler","year":"1997","journal-title":"J Virol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.virusres.2005.10.014","article-title":"Inhibition of PKR by RNA and DNA viruses","volume":"119","author":"JO Langland","year":"2006","journal-title":"Virus Res"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1128\/JVI.78.6.2770-2779.2004","article-title":"Induction of potent humoral and cell-mediated immune responses by attenuated vaccinia virus vectors with deleted serpin genes","volume":"78","author":"FA Legrand","year":"2004","journal-title":"J Virol"},{"key":"ref36","article-title":"Generation of recombinant vaccinia viruses","year":"1991"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1128\/JVI.67.6.3319-3325.1993","article-title":"Dissociation of progeny vaccinia virus from the cell membrane is regulated by a viral envelope glycoprotein: effect of a point mutation in the lectin homology domain of the A34R gene","volume":"67","author":"R Blasco","year":"1993","journal-title":"J Virol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/0042-6822(92)90445-U","article-title":"Restricted replication of ectromelia virus in cell culture correlates with mutations in virus-encoded host range gene","volume":"187","author":"W Chen","year":"1992","journal-title":"Virology"},{"key":"ref39","first-page":"16.16.11-16.16.17","article-title":"Expression of proteins in mammalian cells using vaccinia virus vectors. Overview of the vaccinia virus epression system","year":"1991"},{"key":"ref40","first-page":"41","article-title":"Kinetics of ectromelia virus (mousepox) transmission and clinical response in C57BL\/6j, BALB\/cByj and AKR\/J inbred mice","volume":"35","author":"GD Wallace","year":"1985","journal-title":"Lab Anim Sci"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1016\/j.vaccine.2008.03.044","article-title":"Vaccinia viruses with mutations in the E3L gene as potential replication-competent, attenuated vaccines: scarification vaccination","volume":"26","author":"GM Jentarra","year":"2008","journal-title":"Vaccine"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/BF01311044","article-title":"Vaccinia virus: a suitable vehicle for recombinant vaccines?","volume":"106","author":"C Kaplan","year":"1989","journal-title":"Arch Virol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"11537","DOI":"10.1073\/pnas.96.20.11537","article-title":"IL-18 binding and inhibition of interferon gamma induction by human poxvirus-encoded proteins","volume":"96","author":"Y Xiang","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0928-8244(03)00358-4","article-title":"Prevention of lethal respiratory vaccinia infections in mice with interferon-alpha and interferon-gamma","volume":"40","author":"G Liu","year":"2004","journal-title":"FEMS Immunol Med Microbiol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.1128\/JVI.75.7.3185-3196.2001","article-title":"Vaccinia virus blocks gamma interferon signal transduction: viral VH1 phosphatase reverses Stat1 activation","volume":"75","author":"P Najarro","year":"2001","journal-title":"J Virol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1600-065X.1992.tb01413.x","article-title":"Expression of cytokines by recombinant vaccinia viruses: a model for studying cytokines in virus infections in vivo","volume":"127","author":"I Ramshaw","year":"1992","journal-title":"Immunol Rev"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1189\/jlb.0603252","article-title":"Interferon-gamma: an overview of signals, mechanisms and functions","volume":"75","author":"K Schroder","year":"2004","journal-title":"J Leukoc Biol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.virol.2008.11.015","article-title":"Mousepox in the C57BL\/6 strain provides an improved model for evaluating anti-poxvirus therapies","volume":"385","author":"S Parker","year":"2009","journal-title":"Virology"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1099\/vir.0.026237-0","article-title":"Rabbitpox: a model of airborne transmission of smallpox","volume":"92","author":"A Nalca","year":"2011","journal-title":"J Gen Virol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"3409","DOI":"10.1073\/pnas.89.8.3409","article-title":"Vaccinia virus recombinants expressing chimeric proteins of human immunodeficiency virus and gamma interferon are attenuated for nude mice","volume":"89","author":"LD Giavedoni","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/eji.1830200123","article-title":"Immunodeficient mice recover from infection with vaccinia virus expressing interferon-gamma","volume":"20","author":"MR Kohonen-Corish","year":"1990","journal-title":"Eur J Immunol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1046\/j.1440-1711.1999.00829.x","article-title":"Use of recombinant viruses to deliver cytokines influencing the course of experimental bacterial infection","volume":"77","author":"C Cheers","year":"1999","journal-title":"Immunol Cell Biol"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1099\/0022-1317-81-11-2665","article-title":"The in vivo effects of recombinant bovine herpesvirus-1 expressing bovine interferon-gamma","volume":"81","author":"C Raggo","year":"2000","journal-title":"J Gen Virol"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1128\/JVI.71.2.866-872.1997","article-title":"Expression of gamma interferon by simian immunodeficiency virus increases attenuation and reduces postchallenge virus load in vaccinated rhesus macaques","volume":"71","author":"L Giavedoni","year":"1997","journal-title":"J Virol"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.4049\/jimmunol.140.10.3599","article-title":"Enhancement of a secondary antibody response to vesicular stomatitis virus "G" protein by IFN-gamma treatment at primary immunization","volume":"140","author":"KP Anderson","year":"1988","journal-title":"J Immunol"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1126\/science.8456300","article-title":"Multiple defects of immune cell function in mice with disrupted interferon-gamma genes","volume":"259","author":"DK Dalton","year":"1993","journal-title":"Science"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1084\/jem.184.2.557","article-title":"Nitric oxide in Tanzanian children with malaria: inverse relationship between malaria severity and nitric oxide production\/nitric oxide synthase type 2 expression","volume":"184","author":"NM Anstey","year":"1996","journal-title":"J Exp Med"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1128\/JVI.69.2.910-915.1995","article-title":"Gamma interferon-induced, nitric oxide-mediated inhibition of vaccinia virus replication","volume":"69","author":"N Harris","year":"1995","journal-title":"J Virol"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1126\/science.7690156","article-title":"Inhibition of viral replication by interferon-gamma-induced nitric oxide synthase","volume":"261","author":"G Karupiah","year":"1993","journal-title":"Science"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2217\/17460913.2.1.17","article-title":"Human monkeypox: an emerging zoonotic disease","volume":"2","author":"S Parker","year":"2007","journal-title":"Future Microbiol"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"4633","DOI":"10.1128\/JVI.69.8.4633-4639.1995","article-title":"Vaccinia, cowpox, and camelpox viruses encode soluble gamma interferon receptors with novel broad species specificity","volume":"69","author":"A Alcam\u00ed","year":"1995","journal-title":"J Virol"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1099\/0022-1317-83-11-2833","article-title":"The vaccinia virus C12L protein inhibits mouse IL-18 and promotes virus virulence in the murine intranasal model","volume":"83","author":"JA Symons","year":"2002","journal-title":"J Gen Virol"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"9960","DOI":"10.1128\/JVI.77.18.9960-9968.2003","article-title":"Vaccinia virus interleukin-18-binding protein promotes virulence by reducing gamma interferon production and natural killer and T-cell activity","volume":"77","author":"PC Reading","year":"2003","journal-title":"J Virol"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1128\/JVI.65.3.1530-1542.1991","article-title":"Identification and characterization of two nonessential regions of the rabbitpox virus genome involved in virulence","volume":"65","author":"DC Bloom","year":"1991","journal-title":"J Virol"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1128\/JVI.79.4.2133-2140.2005","article-title":"Wiskott-Aldrich syndrome protein is needed for vaccinia virus pathogenesis","volume":"79","author":"S Guerra","year":"2005","journal-title":"J Virol"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.virusres.2005.08.008","article-title":"Improving recombinant MVA immune responses: potentiation of the immune responses to HIV-1 with MVA and DNA vectors expressing Env and the cytokines IL-12 and IFN-gamma","volume":"116","author":"F Abaitua","year":"2006","journal-title":"Virus Res"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.3390\/v2091918","article-title":"Ectromelia virus infections of mice as a model to support the licensure of anti-orthopoxvirus therapeutics","volume":"2","author":"S Parker","year":"2010","journal-title":"Viruses"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.virol.2003.11.015","article-title":"Efficacy of oral active ether lipid analogs of cidofovir in a lethal mousepox model","volume":"318","author":"RM Buller","year":"2004","journal-title":"Virology"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1099\/vir.0.81090-0","article-title":"Ectromelia virus: the causative agent of mousepox","volume":"86","author":"DJ Esteban","year":"2005","journal-title":"J Gen Virol"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"341","DOI":"10.4049\/jimmunol.63.4.341","article-title":"Mouse-pox; infectious ectromelia of mice; a review","volume":"63","author":"F Fenner","year":"1949","journal-title":"J Immunol"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.1128\/JVI.01927-06","article-title":"Poxvirus-encoded gamma interferon binding protein dampens the host immune response to infection","volume":"81","author":"IG Sakala","year":"2007","journal-title":"J Virol"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1006\/viro.1995.1208","article-title":"Species specificity of ectromelia virus and vaccinia virus interferon-gamma binding proteins","volume":"208","author":"K Mossman","year":"1995","journal-title":"Virology"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1128\/JVI.76.3.1124-1134.2002","article-title":"Inhibition of interferons by ectromelia virus","volume":"76","author":"VP Smith","year":"2002","journal-title":"J Virol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0077879","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T11:32:40Z","timestamp":1688556760000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0077879"}},"subtitle":[],"editor":[{"given":"Dipshikha","family":"Chakravortty","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,10,17]]},"references-count":73,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2013,10,17]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0077879","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,17]]}}}